Stockreport

How Investors Are Reacting To Incyte (INCY) Winning EU Approval For Zynyz In Advanced Anal Cancer [Yahoo! Finance]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF treatment of advanced squamous cell carcinoma of the anal canal, supported by Phase 3 POD1UM-303/InterAACT2 data showing improved progression-free survival and no new sa [Read more]